SILIMARIN 200 mg compresse rivestite, Kisqali 200 mg film-coated tablets
GIM35-RIBOSIL
Phase 2 small_molecule active
Quick answer
SILIMARIN 200 mg compresse rivestite, Kisqali 200 mg film-coated tablets for hormone receptor positive, HER2-negative breast cancer is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- hormone receptor positive, HER2-negative breast cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active